Inhaled long-acting bronchodilators

February 4, 2016May 12, 2016

European Clinical Trial Enrolling Patients for COPD Treatment

COPD, News

Pulmatrix Inc., a clinical stage biopharma dedicated to the development of inhaled therapies to address serious pulmonary diseases, recently announced that its European pilot bioequivalence study on PUR0200 for the ... Read more

December 10, 2015

UK COPD Study Highlights High Costs and Burdens of Treatment

COPD, News

A recent study in the journal Respiratory Research notes the high costs and burdens of chronic obstructive pulmonary disease treatment among patients initiating maintenance therapy, and the low rates of patient adherent to treatment. ... Read more